What’s your biggest challenge in characterizing mRNA therapeutics?
There’s currently significant demand for the development of new and improved analytical methods for the characterization of mRNA therapeutics. Check out my blog on an end-to-end LC-MS workflow that enables direct sequence mapping of mRNA and share yo...